1,035
Views
4
CrossRef citations to date
0
Altmetric
Short Communication

Structure-based drug design and biological evaluation of 2-acetamidobenzothiazole derivative as EGFR kinase inhibitor

, , &
Pages 160-165 | Received 15 Dec 2013, Accepted 23 Jan 2014, Published online: 07 Mar 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fia Fathiana Wulan, Tutik Dwi Wahyuningsih, Endang Astuti & Niko Prasetyo. (2023) Towards targeting EGFR and COX-2 inhibitors: comprehensive computational studies on the role of chlorine group in novel thienyl-pyrazoline derivative. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-16.
Read now

Articles from other publishers (3)

Arvind Kumar Jain, C. Karthikeyan, Piyush Trivedi & Anita Dutt Konar. 2023. Computational Modeling of Drugs Against Alzheimer’s Disease. Computational Modeling of Drugs Against Alzheimer’s Disease 165 185 .
Moustafa T. Gabr. (2018) Antioxidant, α-glucosidase inhibitory and in vitro antitumor activities of coumarin-benzothiazole hybrids . Heterocyclic Communications 24:5, pages 243-247.
Crossref
Moustafa T. Gabr, Nadia S. El-Gohary, Eman R. El-Bendary & Mohamed M. El-Kerdawy. (2014) Synthesis and in vitro antitumor activity of new series of benzothiazole and pyrimido[2,1-b]benzothiazole derivatives. European Journal of Medicinal Chemistry 85, pages 576-592.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.